Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Spiegel JY, Patel S, Muffly L, Hossain NM, Oak J, Baird JH, Frank MJ, Shiraz P, Sahaf B, Craig J, Iglesias M, Younes S, Natkunam Y, Ozawa MG, Yang E, Tamaresis J, Chinnasamy H, Ehlinger Z, Reynolds W, Lynn R, Rotiroti MC, Gkitsas N, Arai S, Johnston L, Lowsky R, Majzner RG, Meyer E, Negrin RS, Rezvani AR, Sidana S, Shizuru J, Weng WK, Mullins C, Jacob A, Kirsch I, Bazzano M, Zhou J, Mackay S, Bornheimer SJ, Schultz L, Ramakrishna S, Davis KL, Kong KA, Shah NN, Qin H, Fry T, Feldman S, Mackall CL, Miklos DB. Spiegel JY, et al. Among authors: sidana s. Nat Med. 2021 Aug;27(8):1419-1431. doi: 10.1038/s41591-021-01436-0. Epub 2021 Jul 26. Nat Med. 2021. PMID: 34312556 Free PMC article. Clinical Trial.
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience.
Kourelis T, Bansal R, Berdeja J, Siegel D, Patel K, Mailankody S, Htut M, Shah N, Wong SW, Sidana S, Cowan AJ, Alsina M, Cohen A, Holstein SA, Bergsagel L, Ailawadhi S, Raje N, Dhakal B, Rossi A, Lin Y. Kourelis T, et al. Among authors: sidana s. Transplant Cell Ther. 2023 Apr;29(4):255-258. doi: 10.1016/j.jtct.2023.01.012. Epub 2023 Jan 18. Transplant Cell Ther. 2023. PMID: 36681151 Free PMC article.
Reply to R. Chakraborty et al.
Hansen DK, Sidana S, Peres LC, Patel KK. Hansen DK, et al. Among authors: sidana s. J Clin Oncol. 2023 Jul 10;41(20):3658-3659. doi: 10.1200/JCO.23.00568. Epub 2023 May 26. J Clin Oncol. 2023. PMID: 37235841 Free PMC article. No abstract available.
CAR T-cell therapy: is it prime time in myeloma?
Sidana S, Shah N. Sidana S, et al. Blood Adv. 2019 Nov 12;3(21):3473-3480. doi: 10.1182/bloodadvances.2019000370. Blood Adv. 2019. PMID: 31714964 Free PMC article. Review.
CAR T-cell therapy: is it prime time in myeloma?
Sidana S, Shah N. Sidana S, et al. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):260-265. doi: 10.1182/hematology.2019000370. Hematology Am Soc Hematol Educ Program. 2019. PMID: 31808895 Free PMC article. Review.
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma.
Lemieux C, Muffly LS, Rezvani A, Lowsky R, Iberri DJ, Craig JK, Frank MJ, Johnston LJ, Liedtke M, Negrin R, Weng WK, Meyer E, Shizuru J, Shiraz P, Arai S, Miklos DB, Sidana S. Lemieux C, et al. Among authors: sidana s. Bone Marrow Transplant. 2021 Feb;56(2):368-375. doi: 10.1038/s41409-020-01026-7. Epub 2020 Aug 11. Bone Marrow Transplant. 2021. PMID: 32782351 Free PMC article.
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents.
Lemieux C, Johnston LJ, Lowsky R, Muffly LS, Craig JK, Shiraz P, Rezvani A, Frank MJ, Weng WK, Meyer E, Shizuru J, Arai S, Negrin R, Miklos DB, Sidana S. Lemieux C, et al. Among authors: sidana s. Biol Blood Marrow Transplant. 2020 Dec;26(12):e328-e332. doi: 10.1016/j.bbmt.2020.08.035. Epub 2020 Sep 19. Biol Blood Marrow Transplant. 2020. PMID: 32961371 Free PMC article.
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma.
Baird JH, Frank MJ, Craig J, Patel S, Spiegel JY, Sahaf B, Oak JS, Younes SF, Ozawa MG, Yang E, Natkunam Y, Tamaresis J, Ehlinger Z, Reynolds WD, Arai S, Johnston L, Lowsky R, Meyer E, Negrin RS, Rezvani AR, Shiraz P, Sidana S, Weng WK, Davis KL, Ramakrishna S, Schultz L, Mullins C, Jacob A, Kirsch I, Feldman SA, Mackall CL, Miklos DB, Muffly L. Baird JH, et al. Among authors: sidana s. Blood. 2021 Apr 29;137(17):2321-2325. doi: 10.1182/blood.2020009432. Blood. 2021. PMID: 33512414 Free PMC article.
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma.
Baird JH, Epstein DJ, Tamaresis JS, Ehlinger Z, Spiegel JY, Craig J, Claire GK, Frank MJ, Muffly L, Shiraz P, Meyer E, Arai S, Brown JW, Johnston L, Lowsky R, Negrin RS, Rezvani AR, Weng WK, Latchford T, Sahaf B, Mackall CL, Miklos DB, Sidana S. Baird JH, et al. Among authors: sidana s. Blood Adv. 2021 Jan 12;5(1):143-155. doi: 10.1182/bloodadvances.2020002732. Blood Adv. 2021. PMID: 33570626 Free PMC article.
123 results